Drug Trial Radar · NCT04529148
The Efficacy and Safety of Ginkgo Biloba Dropping Pills in the Treatment of Coronary Heart Disease With Stable Angina Pectoris and Depression
Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74
Actual
Start
Nov 30, 2020
Primary completion
Aug 18, 2022
Study completion Aug 18, 2022
Sponsor
- Lead sponsor
- Wanbangde Pharmaceutical Group Co., LTDIndustry
- Sponsor type
- Industry
- Collaborators
- The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
- First posted
- Aug 27, 2020
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the clinical efficacy of Ginkgo biloba dropping pills on improving the frequency of angina pectoris and the life quality of patients with stable angina pectoris and depression symptoms on the basis of the best western medicine treatment; Study on the clinical pharmacological mechanism of Ginkgo biloba dropping pills.
Conditions
- Stable Angina Pectoris Associated With Depression
Interventions
Ginkgo biloba dropping pills,best western medicine treatmentDrug
oral
Mimetic drug of ginkgo biloba dropping pills,best western medicine treatmentDrug
oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Score of Seattle Angina Questionnaire(SAQ )Time frame: at the 0-week
- Score of Seattle Angina Questionnaire(SAQ )Time frame: at the 4-week
- Score of Seattle Angina Questionnaire(SAQ )Time frame: at the 8-week
- Score of Seattle Angina Questionnaire(SAQ )Time frame: at the 12-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 0-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 1-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 2-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 3-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 4-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 5-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 6-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 7-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 8-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 9-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 10-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 11-week
- Frequency of angina pectoris related symptoms every weekTime frame: at the 12-week
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Foshan Chancheng Central Hospital
Foshan, Guangdong, China
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, China
Shenzhen Luohu District People's Hospital
Shenzhen, Guangdong, China
The Second Affiliated Hospital of Guizhou University of Chinese Medicine
Guiyang, Guizhou, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.